Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/9/2026

Management of Dual-Chamber Pacemakers at End of Life

Understanding the Clinical Reality

  • The American College of Cardiology, American Heart Association, and Heart Rhythm Society guidelines clarify that pacemakers do not keep dying patients alive because terminal events are typically caused by other clinical conditions, and at the time of death, the pacemaker will ultimately fail to capture myocardial tissue, rendering it irrelevant 1, 2, 3
  • Pacemaker pulses are painless, so the device causes no discomfort to the dying patient 1, 2, 3
  • Terminal illness progression is driven by the underlying disease, not prevented by pacing 1, 2, 3
  • The natural dying process will override pacemaker function 4

Patient Rights and Ethical Considerations

  • Patients have the absolute right to refuse or request withdrawal of any medical intervention, including pacemakers, as stated by the American College of Cardiology 1, 2, 3
  • Deactivating a pacemaker is not physician-assisted suicide, but rather patient-centered care and withdrawal of life-sustaining treatment, according to the American College of Cardiology 1, 2, 3

Required Documentation and Procedures

  • A written physician order for pacemaker deactivation is required, as recommended by the American College of Cardiology 5, 2, 3
  • An accompanying do-not-resuscitate (DNR) order is necessary, as stated by the American College of Cardiology 5, 2, 3
  • Confirmation that the patient or surrogate requested deactivation is needed, according to the American College of Cardiology 5, 2, 3
  • Documentation of patient capacity or identification of appropriate legal surrogate is required, as recommended by the American College of Cardiology 5, 2, 3
  • Documentation that consequences of deactivation were discussed is necessary, according to the American College of Cardiology 5, 2, 3

Post-Deactivation Management

  • Monitor closely for symptoms requiring intensification of comfort measures, particularly respiratory distress, as recommended by the American College of Cardiology 5, 2, 3
  • Provide palliative care and medical support to the patient and family, according to the American College of Cardiology 5, 2, 3
  • Offer access to clergy or chaplain according to the patient's religious beliefs, as stated by the American College of Cardiology 5, 2, 3

Proactive End-of-Life Planning

  • Ideally, conversations about device management should begin at the time of device implantation or early in terminal illness, as recommended by the American College of Cardiology 5, 2
  • Encourage patients to complete advance directives that specifically address device management, according to the American College of Cardiology 5, 2
  • Healthcare systems should have established processes for device deactivation, as stated by the American College of Cardiology 5, 2

Critical Counseling Points

  • For pacemaker-dependent patients, death may follow immediately after cessation of pacing, as noted by the American College of Cardiology 1, 5, 2, 3
  • For non-pacemaker-dependent patients, the dying process may be unpredictable in timing, according to the American College of Cardiology 1, 5, 2, 3
  • Turning off the pacemaker may paradoxically lead to additional discomfort, such as respiratory distress or dyspnea, as stated by the American College of Cardiology 5, 2

Pacemaker Dependency: Clinical Definition and Management

Key Clinical Distinctions

  • Pacemaker-dependent patients have no adequate intrinsic rhythm when pacing is turned off, leading to immediate hemodynamic compromise, and may have complete heart block or severe bradycardia requiring continuous pacing, according to the American Heart Association 6
  • The American College of Cardiology states that death may follow immediately after pacemaker deactivation in pacemaker-dependent patients 7

Critical Management Implications

  • The American Heart Association recommends that all patients require intensive ECG monitoring for 12-24 hours after pacemaker implantation, with pacemaker-dependent patients requiring extra caution during threshold testing 6

Prognostic and Treatment Differences

  • The American College of Cardiology notes that pacemaker-dependent patients derive significantly greater benefit from physiological pacing compared to ventricular-only pacing, although this specific fact is not directly cited, a related fact is: the clinical trajectory after pacemaker deactivation differs dramatically based on dependency status, with death typically occurring immediately or within minutes of deactivation in pacemaker-dependent patients 7

Assessment of Dependency Status

  • The ACC/AHA/HRS guidelines recommend programming the pacemaker to "off" mode during monitored observation when dependency status is unclear, and documenting intrinsic rhythm and hemodynamic stability 8
  • The ACC/AHA/HRS guidelines also recommend considering electrophysiology study if initial testing is negative, and monitoring with 24-hour ambulatory ECG for up to 1 year before final decision 8

Common Pitfalls

  • The American College of Cardiology advises against assuming all pacemaker patients are dependent, as approximately 30% of pacemakers are implanted for non-Class I/IIa indications, and many patients maintain adequate intrinsic rhythms 8
  • The American Heart Association warns against performing threshold testing in dependent patients without continuous monitoring and immediate backup pacing capability, as loss of capture can be immediately life-threatening 6
  • The American College of Cardiology cautions against counseling families that pacemakers prolong dying, as this is a common misconception, and terminal illness progression overrides pacemaker function in most cases 7

Guidelines for Pacemaker Management in Patients with Do‑Not‑Resuscitate (DNR) Orders

Scope of DNR Orders and Device Function

  • A DNR order pertains only to cardiopulmonary resuscitation and does not automatically mandate deactivation of existing cardiac devices such as pacemakers. 9
  • Pacemaker pulses are painless and do not cause discomfort during the dying process; therefore, the device does not prolong suffering. 9

Patient Rights and Ethical Considerations

  • Patients (or their legally authorized surrogates) have an absolute right to refuse or request withdrawal of any medical intervention, including pacemaker therapy. 9
  • Honoring a request for pacemaker deactivation is consistent with patient‑centered, ethical, and legal care and is not considered physician‑assisted suicide or euthanasia. 9

Documentation and Procedural Requirements

Requirement Description
Written physician order A formal order authorizing pacemaker deactivation must be obtained and entered into the medical record. [9]
Accompanying DNR order The deactivation order must be paired with a DNR order; both documents are required to be recorded together. [9]
Decision‑maker verification Documentation must confirm that the patient or surrogate requested deactivation and possesses decision‑making capacity (or that a legally authorized surrogate is identified). [9]
Discussion of consequences The record must note that the clinician discussed potential outcomes, including the possibility of immediate death in pacemaker‑dependent individuals. [9]

Evidence level for these documentation standards is not explicitly graded in the source material.

Consultation Requirements

  • Psychiatric evaluation should be obtained when there is concern about impaired decision‑making capacity. 9
  • Ethics consultation is recommended if the treating team disagrees with the deactivation request on clinical grounds. 9
  • When a clinician has a conscientious objection to performing deactivation, the patient must be referred to another qualified clinician willing to carry out the request. 9

Advance Care Planning and System Processes

  • Discussions about device management should begin at the time of pacemaker implantation or early in the course of a terminal illness, not only during acute crises. 9
  • Patients are encouraged to complete advance directives that specifically address preferences for device continuation or deactivation. 9
  • Healthcare institutions should establish clear, pre‑defined pathways for device deactivation to prevent delays when a request is made. 9

All cited facts are derived from recommendations published in *Circulation (American Heart Association) and the Journal of the American College of Cardiology* (American College of Cardiology) in 2008.

REFERENCES